Leaderboard

En | De
Sie sind hier: Gastroenterologie » Pankreas » Neoplasie 09. Januar 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2937  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 58725  
   
Esophageal neuroendocrine carcinoma: molecular insights, diagnostic advances, and emerging treatment strategies.
Clin Transl Oncol
Wu XW, Du Y, Jiao Y.
PMID: 41507459 [PubMed - as supplied by publisher]


Oncological Adequacy of R1 Vascular Margin in Minimally Invasive Liver Surgery for Hepatocellular Carcinoma and Colorectal Liver Metastases: A Meta-analysis.
Ann Surg Oncol
Procopio F, Memeo R, Del Fabbro D, Abdelhadi S, Reissfelder C, Edwin B, Milana F, Troisi RI, Torzilli G, Minimally Invasive R1 Vascular Group.
PMID: 41507450 [PubMed - as supplied by publisher]


Obesity and Cancer: Mechanisms, Epidemiological Evidence, and Potential Risk Reduction.
J Obes Metab Syndr
Lim JS, Kim S, Cho IY, Shin DW.
PMID: 41506747 [PubMed - as supplied by publisher]


Radiopathomics Signature for Prognosis and Prediction of Chemotherapy Benefit in Unresectable Pancreatic Cancer.
JCO Precis Oncol
Hu X, Liang K, Liu Y, Zhang Z, Liu G, Tan X.
PMID: 41505682 [PubMed - indexed for MEDLINE]


Erratum: Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial.
J Clin Oncol
Fietkau R, Ghadimi M, Grützmann R, Wittel UA, Jacobasch L, Uhl W, Croner RS, Bechstein WO, Neumann UP, Waldschmidt D, Boeck S, Moosmann N, Reinacher-Schick AC, Golcher H, Adler W, Semrau S, Lubgan D, Kallies A, Hecht M, Tischoff I, Tannapfel A, Frey B, Oettle H, CONKO Study Group.
PMID: 41505667 [PubMed - as supplied by publisher]


Graphene Quantum Dots in Cancer Diagnostics and Therapeutics: Advances in Biosensing, Imaging, and Treatment Applications.
Curr Med Sci
Bhise MR, Trivedi V, Devi S, Tripathi AK, Kumar J, Katta S, Raval AV, Shamim S, Kumar R, Kumar P.
PMID: 41505072 [PubMed - as supplied by publisher]


Comparative study of the efficacy and safety of PSOX and SOX plus sintilimab regimens as first-line treatments for advanced gastric cancer.
Anticancer Drugs
Zhang T, Yang W, Zhang C, Wang K, Li H.
PMID: 41503711 [PubMed - as supplied by publisher]


Three-Dimensional Tumor Spheroids of Pancreatic and Colorectal Cancer Cell Lines for High-Throughput Screening of Drug Candidates.
ACS Omega
Trofimov M, Bulatov I, Donskaia I, Efremov A, Litau E, Lavrinenko V, Popov V, Petrova V, Bukatin A, Tyazhelnikov S.
PMID: 41502656 [PubMed]


Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study.
Oncol Res
Chuang CH, Tsai PK, Kao SW, Wang YH, Yeh CB.
PMID: 41502515 [PubMed - indexed for MEDLINE]


Perioperative tislelizumab plus lenvatinib treatment for resectable hepatocellular carcinoma at high risk of recurrence: single-arm phase II trial.
Nat Commun
Chen L, Zhai S, Liu Y, Gong W, Fang F, Wu Q, Cui Y, Zhang W, Li H, Li Y, Hao J, Song T.
PMID: 41501032 [PubMed - as supplied by publisher]


Re-expression of embryonic stem cell markers in malignant tissue: an observational study in pancreatic cancer.
Anat Cell Biol
Swain S, Rout S, Raman S, Ravi PK, Babu S, Mishra PR.
PMID: 41500957 [PubMed - as supplied by publisher]


Cross-Cancer Perspectives on CD40 Agonist Therapy: Modulating the Tumor Immune Microenvironment.
J Biochem Mol Toxicol
Hua X, Hua J, Wang Y.
PMID: 41499321 [PubMed - indexed for MEDLINE]


Stimuli-Responsive Supramolecular Biomaterials for Cancer Theranostics.
Adv Sci (Weinh)
Hu W, Ye B, Yu G, Huang F, Mao Z.
PMID: 41498647 [PubMed - as supplied by publisher]


COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms.
Oncotarget
Kuperwasser C, El-Deiry WS.
PMID: 41498242 [PubMed - indexed for MEDLINE]


CRISPR-Cas13a diagnostics for circulating microbial transcripts in pancreatic cancer.
Ann Med Surg (Lond)
Mehmood MS, Iqbal I, Hajj F.
PMID: 41496941 [PubMed]


Multifaceted role of interleukin-32 in inflammatory diseases and cancer.
Biomed Pharmacother
Gu SM, Lee YS, Yoon DY, Kim HM, Na IH, Han SB, Roh YS, Hong JT.
PMID: 41496339 [PubMed - as supplied by publisher]


Integrating nontargeted metabolomics and machine learning to assess PFAS exposure associations with liver cancer risk.
Environ Int
Wu T, Fang J, Hong J, Jiang Y, Du K, Zhang W, Zhang S, Pan T, Fu L, Mao W, Jin H, Hu W, Zheng S, Cao L.
PMID: 41496226 [PubMed - as supplied by publisher]


Organoids in translation: a bench-to-bedside framework for pancreatic cancer precision medicine.
J Transl Med
Malik DA, Schmieder EAS, Genova G, Gaskins J, Martin Ii RCG.
PMID: 41495743 [PubMed - as supplied by publisher]


Decision support tools for pancreatic cancer detection: External validation in Australian primary care.
Br J Gen Pract
Schrader S, Rafiq M, Martinez Gutierrez J, Waterhouse M, Lee B, Neale R, Emery J.
PMID: 41494778 [PubMed - as supplied by publisher]


Overcoming barriers in cancer therapy with oncolytic adenoviruses: Engineering strategies and clinical perspectives.
Pathol Res Pract
Sharma R, Sharma R, Dua K, Gupta G, Chellappan DK, Singh SK, Singh TG, Negi P.
PMID: 41494274 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 58725    Seite 1 von 2937  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1